Molina-López, Cristina
Hurtado-Navarro, Laura
García, Carlos J.
Angosto-Bazarra, Diego
Vallejo, Fernando http://orcid.org/0000-0003-3343-6479
Tapia-Abellán, Ana
Marques-Soares, Joana R.
Vargas, Carmen
Bujan-Rivas, Segundo
Tomás-Barberán, Francisco A. http://orcid.org/0000-0002-0790-1739
Arostegui, Juan I. http://orcid.org/0000-0003-4757-504X
Pelegrin, Pablo http://orcid.org/0000-0002-9688-1804
Article History
Received: 2 May 2023
Accepted: 11 January 2024
First Online: 6 February 2024
Competing interests
: P.P. declares that he is an inventor in a patent filled on March 2020 by the <i>Fundación para la Formación e Investigación Sanitaria de la Región de Murcia</i> (PCT/EP2020/056729) for a method to identify NLRP3-immunocompromised sepsis patients. P.P., L.H.-N. and D.A.-B. are co-founders and have shares in Viva in vitro diagnostics SL, but declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The remaining authors declare no competing interests.